Antihypertensive Effects of Two Novel Angiotensin I-Converting Enzyme (ACE) Inhibitory Peptides from Gracilariopsis lemaneiformis (Rhodophyta) in Spontaneously Hypertensive Rats (SHRs)

Marine Drugs
Zhenzhen DengQuanbin Zhang

Abstract

A variety of biologically active products have been isolated from Gracilariopsis lemaneiformis. In the present study, two novel angiotensin-converting enzyme (ACE) inhibitory peptides, FQIN [M(O)] CILR, and TGAPCR, were screened and identified from G. lemaneiformis protein hydrolysates by LC-MS/MS. The IC50 values of FQIN [M(O)] CILR and TGAPCR were 9.64 ± 0.36 μM and 23.94 ± 0.82 μM, respectively. In the stability study, both peptides showed stabilities of pH, temperature, simulated gastrointestinal digestion, and ACE hydrolysis. The Lineweaver⁻Burk plot showed that the two peptides were noncompetitive inhibitors of ACE. Molecular docking simulated the intermolecular interactions of two peptides and ACE, and the two peptides formed hydrogen bonds with the active pockets of ACE. However, FQIN [M(O)] CILR was more closely linked to the active pockets of ACE, thereby exerting better ACE inhibition. Spontaneously hypertensive rats (SHRs) were studied with an oral dose of 10 mg/kg body weight. Both peptides reduced systolic blood pressure (SBP) and diastolic blood pressure (DBP) in SHRs, of which FQIN [M(O)] CILR was able to reduce the systolic blood pressure by 34 mmHg (SBP) (p < 0.05). Therefore, FQIN [M(O)] CILR was an excellent...Continue Reading

References

Sep 1, 1994·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·J Martin, F U Hartl
Dec 22, 1999·Immunopharmacology·H Fujita, M Yoshikawa
Jan 24, 2003·Nature·Ramanathan NateshK Ravi Acharya
Jul 5, 2003·Bioscience, Biotechnology, and Biochemistry·Megumi KubaMasaaki Yasuda
Aug 23, 2005·The Journal of Nutritional Biochemistry·Huan Li, Rotimi E Aluko
Nov 9, 2005·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·G CornélissenFranz Halberg
Sep 20, 2008·Journal of Medicinal Food·Mariza FariaFlávia Maria Netto
May 1, 2012·European Journal of Medicinal Chemistry·A C RohitH S Aparna
May 8, 2014·International Journal of Inflammation·Maricica PacurariKenneth Ndebele
May 20, 2014·Food Chemistry·Elizabeth EscuderoFidel Toldrá
Apr 18, 2015·Annual Review of Food Science and Technology·Rotimi E Aluko

❮ Previous
Next ❯

Citations

Jun 11, 2020·Natural Product Reports·Fatma H Al-Awadhi, Hendrik Luesch
Aug 31, 2019·Marine Drugs·Tatiana V Ovchinnikova
Feb 6, 2020·PloS One·Rana Adnan TahirSheikh Arslan Sehgal
Feb 18, 2021·Journal of Agricultural and Food Chemistry·Yanbo HuangSong-Qing Hu

❮ Previous
Next ❯

Software Mentioned

SPSS
Discovery Studio
CDOCKER
Mascot
Innovagen
CHARMm

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.